Business Unit Lead – Advanced Therapy Medicinal Products (ATMP) / Cell & Gene Therapies (CGT)
Bio
With a background in Cell & Health sciences & over 18 years spent in industry, Tom is currently leading the PrimeVigilance ATMP/CGT business Unit. Throughout his career Tom has held positions at global, small & mid sized CRO and Pharma companies, within the field of Safety & Pharmacovigilance. Using his vast his experience within cell and gene therapy, Tom supports PrimeVigilance's growing client base, naviagting this complex landscape.